Impact of estrogen replacement therapy on outcomes following total shoulder arthroplasty: a propensity-matched retrospective cohort study of 1,779 patients

Background: While estrogen is essential for bone remodeling, its impact on joint health is more nuanced. Previous studies suggest that high estrogen states, including those induced by estrogen replacement therapy (ERT), are associated with osteoarthritis and an increased risk of revisions after hip...

Full description

Saved in:
Bibliographic Details
Main Authors: Seyedeh Zahra Mousavi, BS, Ethan R. Harris, BS, Sanjana Agarwal, BS, Prasenjit Saha, BA, Eve R. Glenn, ScB, Henry M. Fox, MD, Umasuthan Srikumaran, MD, MBA, MPH
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:JSES International
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S266663832500146X
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849319639356538880
author Seyedeh Zahra Mousavi, BS
Ethan R. Harris, BS
Sanjana Agarwal, BS
Prasenjit Saha, BA
Eve R. Glenn, ScB
Henry M. Fox, MD
Umasuthan Srikumaran, MD, MBA, MPH
author_facet Seyedeh Zahra Mousavi, BS
Ethan R. Harris, BS
Sanjana Agarwal, BS
Prasenjit Saha, BA
Eve R. Glenn, ScB
Henry M. Fox, MD
Umasuthan Srikumaran, MD, MBA, MPH
author_sort Seyedeh Zahra Mousavi, BS
collection DOAJ
description Background: While estrogen is essential for bone remodeling, its impact on joint health is more nuanced. Previous studies suggest that high estrogen states, including those induced by estrogen replacement therapy (ERT), are associated with osteoarthritis and an increased risk of revisions after hip and/or knee arthroplasty. Given the rise in total shoulder arthroplasty (TSA) cases, it is important to investigate factors that may impact its outcomes. This study aimed to evaluate whether ERT use impacts TSA outcomes at 2, 4, and 10 years postoperatively. Materials and methods: This was a retrospective cohort study of females aged ≥55 years who underwent TSA, using the TriNetX Research Network. Patients were stratified by ERT use for at least 1-5 years preoperatively. One-to-one propensity score matching was performed based on age, race, bone density, osteoarthritis, and other comorbidities. Primary outcomes were revision rates at 2, 4, and 10 years. Secondary outcomes included prosthetic joint infections, mechanical complications, and shoulder instability, as well as 90-day postoperative medical complications. Tests of significance and risk ratios (RR) were calculated to compare outcomes with an alpha of <0.05. Results: After matching, 1,779 patients were included in each group. At 90 days, the ERT cohort had a higher risk of deep vein thrombosis (RR =1.91; P = .012). At 2 and 4 years postoperatively, the ERT group had a significantly higher risk of revisions (RR = 1.71 and 1.59, respectively), shoulder instability (RR = 1.81 and 1.80), and overall mechanical complications (RR = 1.60 and 1.67). At 10 years, the risk for revisions (RR = 1.59; P = .002) and mechanical complications (RR = 1.43; P = .005) persisted. Conclusion: Our findings suggest that ERT is associated with long-term increased risk of revision procedures and mechanical complications following TSA. This demonstrates the complex relationship between estrogen and bone health, highlighting the need for future studies investigating the impact of ERT on implant survival and osseointegration.
format Article
id doaj-art-d9de979a2e284c6599e32d97da5b785a
institution Kabale University
issn 2666-6383
language English
publishDate 2025-07-01
publisher Elsevier
record_format Article
series JSES International
spelling doaj-art-d9de979a2e284c6599e32d97da5b785a2025-08-20T03:50:21ZengElsevierJSES International2666-63832025-07-01941345135110.1016/j.jseint.2025.04.022Impact of estrogen replacement therapy on outcomes following total shoulder arthroplasty: a propensity-matched retrospective cohort study of 1,779 patientsSeyedeh Zahra Mousavi, BS0Ethan R. Harris, BS1Sanjana Agarwal, BS2Prasenjit Saha, BA3Eve R. Glenn, ScB4Henry M. Fox, MD5Umasuthan Srikumaran, MD, MBA, MPH6The Department of Orthopaedic Surgery, The Johns Hopkins University, Baltimore, MD, USA; Corresponding author: Seyedeh Zahra Mousavi, BS, Department of Orthopaedic Surgery, The Johns Hopkins University School of Medicine, 601 North Caroline Street, Baltimore, MD 21287, USA.The Department of Orthopaedic Surgery, The Johns Hopkins University, Baltimore, MD, USASchool of Medicine, The Johns Hopkins University, Baltimore, MD, USAThe Department of Orthopaedic Surgery, The Johns Hopkins University, Baltimore, MD, USASchool of Medicine, The Johns Hopkins University, Baltimore, MD, USAThe Department of Orthopaedic Surgery, The Johns Hopkins University, Baltimore, MD, USAThe Department of Orthopaedic Surgery, The Johns Hopkins University, Baltimore, MD, USABackground: While estrogen is essential for bone remodeling, its impact on joint health is more nuanced. Previous studies suggest that high estrogen states, including those induced by estrogen replacement therapy (ERT), are associated with osteoarthritis and an increased risk of revisions after hip and/or knee arthroplasty. Given the rise in total shoulder arthroplasty (TSA) cases, it is important to investigate factors that may impact its outcomes. This study aimed to evaluate whether ERT use impacts TSA outcomes at 2, 4, and 10 years postoperatively. Materials and methods: This was a retrospective cohort study of females aged ≥55 years who underwent TSA, using the TriNetX Research Network. Patients were stratified by ERT use for at least 1-5 years preoperatively. One-to-one propensity score matching was performed based on age, race, bone density, osteoarthritis, and other comorbidities. Primary outcomes were revision rates at 2, 4, and 10 years. Secondary outcomes included prosthetic joint infections, mechanical complications, and shoulder instability, as well as 90-day postoperative medical complications. Tests of significance and risk ratios (RR) were calculated to compare outcomes with an alpha of <0.05. Results: After matching, 1,779 patients were included in each group. At 90 days, the ERT cohort had a higher risk of deep vein thrombosis (RR =1.91; P = .012). At 2 and 4 years postoperatively, the ERT group had a significantly higher risk of revisions (RR = 1.71 and 1.59, respectively), shoulder instability (RR = 1.81 and 1.80), and overall mechanical complications (RR = 1.60 and 1.67). At 10 years, the risk for revisions (RR = 1.59; P = .002) and mechanical complications (RR = 1.43; P = .005) persisted. Conclusion: Our findings suggest that ERT is associated with long-term increased risk of revision procedures and mechanical complications following TSA. This demonstrates the complex relationship between estrogen and bone health, highlighting the need for future studies investigating the impact of ERT on implant survival and osseointegration.http://www.sciencedirect.com/science/article/pii/S266663832500146XEstrogen replacement therapyTotal shoulder arthroplastyOrthopedic outcomesOsteoarthritisJoint healthShoulder surgery
spellingShingle Seyedeh Zahra Mousavi, BS
Ethan R. Harris, BS
Sanjana Agarwal, BS
Prasenjit Saha, BA
Eve R. Glenn, ScB
Henry M. Fox, MD
Umasuthan Srikumaran, MD, MBA, MPH
Impact of estrogen replacement therapy on outcomes following total shoulder arthroplasty: a propensity-matched retrospective cohort study of 1,779 patients
JSES International
Estrogen replacement therapy
Total shoulder arthroplasty
Orthopedic outcomes
Osteoarthritis
Joint health
Shoulder surgery
title Impact of estrogen replacement therapy on outcomes following total shoulder arthroplasty: a propensity-matched retrospective cohort study of 1,779 patients
title_full Impact of estrogen replacement therapy on outcomes following total shoulder arthroplasty: a propensity-matched retrospective cohort study of 1,779 patients
title_fullStr Impact of estrogen replacement therapy on outcomes following total shoulder arthroplasty: a propensity-matched retrospective cohort study of 1,779 patients
title_full_unstemmed Impact of estrogen replacement therapy on outcomes following total shoulder arthroplasty: a propensity-matched retrospective cohort study of 1,779 patients
title_short Impact of estrogen replacement therapy on outcomes following total shoulder arthroplasty: a propensity-matched retrospective cohort study of 1,779 patients
title_sort impact of estrogen replacement therapy on outcomes following total shoulder arthroplasty a propensity matched retrospective cohort study of 1 779 patients
topic Estrogen replacement therapy
Total shoulder arthroplasty
Orthopedic outcomes
Osteoarthritis
Joint health
Shoulder surgery
url http://www.sciencedirect.com/science/article/pii/S266663832500146X
work_keys_str_mv AT seyedehzahramousavibs impactofestrogenreplacementtherapyonoutcomesfollowingtotalshoulderarthroplastyapropensitymatchedretrospectivecohortstudyof1779patients
AT ethanrharrisbs impactofestrogenreplacementtherapyonoutcomesfollowingtotalshoulderarthroplastyapropensitymatchedretrospectivecohortstudyof1779patients
AT sanjanaagarwalbs impactofestrogenreplacementtherapyonoutcomesfollowingtotalshoulderarthroplastyapropensitymatchedretrospectivecohortstudyof1779patients
AT prasenjitsahaba impactofestrogenreplacementtherapyonoutcomesfollowingtotalshoulderarthroplastyapropensitymatchedretrospectivecohortstudyof1779patients
AT everglennscb impactofestrogenreplacementtherapyonoutcomesfollowingtotalshoulderarthroplastyapropensitymatchedretrospectivecohortstudyof1779patients
AT henrymfoxmd impactofestrogenreplacementtherapyonoutcomesfollowingtotalshoulderarthroplastyapropensitymatchedretrospectivecohortstudyof1779patients
AT umasuthansrikumaranmdmbamph impactofestrogenreplacementtherapyonoutcomesfollowingtotalshoulderarthroplastyapropensitymatchedretrospectivecohortstudyof1779patients